[1]
Kulkarni, A.A. et al. 2015. RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial Alliance N08C1. Acta Oncologica. 54, 8 (Sep. 2015), 1227–1229. DOI:https://doi.org/10.3109/0284186X.2014.985388.